Literature DB >> 1580230

Sleep-terror disorder in children: the role of self-hypnosis in management.

D P Kohen1, M W Mahowald, G M Rosen.   

Abstract

This paper describes four children, ages 8 to 12 years, with frequent, prolonged, or dangerous disorders of arousal. None had any significant psychological or behavioral problems. Each had a polysomnogram that showed sudden arousals out of slow-wave sleep associated with complex behavior. All responded to a short course of imipramine, 20 to 60 mg at bedtime, followed by and in conjunction with training in relaxation and mental imagery (self-hypnosis). Once the correct diagnosis was made, the treatment strategy was to (1) demystify the symptom complex through education, (2) establish prompt control of the symptoms with the use of imipramine, (3) train the children in self-regulation with self-hypnosis, and (4) discontinue the medication while maintaining control of the arousals. Over a 2-3 year follow-up all children remain asymptomatic. This is the first report of successful use of self-hypnosis for the treatment of polysomnogram-proven disorders of arousal in the pediatric population. Also reported are seven additional children who were treated equally successfully with hypnosis without the use of medication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580230     DOI: 10.1080/00029157.1992.10402853

Source DB:  PubMed          Journal:  Am J Clin Hypn        ISSN: 0002-9157


  4 in total

1.  L -5-Hydroxytryptophan treatment of sleep terrors in children.

Authors:  Oliviero Bruni; Raffaele Ferri; Silvia Miano; Elisabetta Verrillo
Journal:  Eur J Pediatr       Date:  2004-05-14       Impact factor: 3.183

Review 2.  Clinical Hypnosis with Children and Adolescents-What? Why? How?: Origins, Applications, and Efficacy.

Authors:  Daniel P Kohen; Pamela Kaiser
Journal:  Children (Basel)       Date:  2014-08-12

Review 3.  Integrating Pediatric Hypnosis with Complementary Modalities: Clinical Perspectives on Personalized Treatment.

Authors:  Pamela Kaiser; Daniel P Kohen; Melanie L Brown; Rebecca L Kajander; Andrew J Barnes
Journal:  Children (Basel)       Date:  2018-08-07

Review 4.  Overcoming Depression with 5-HT2A Receptor Ligands.

Authors:  Agata Zięba; Piotr Stępnicki; Dariusz Matosiuk; Agnieszka A Kaczor
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.